What Should I Expect Before and After FFI Genetic Testing?

Predictive genetic testing for fatal familial insomnia (FFI) is for healthy, asymptomatic people who have a family history of the disease and want to know if they carry the genetic risk. It is a deeply personal, voluntary decision. Because there is currently no proven preventive treatment, testing involves much more than a simple blood draw.

Many specialist programs use a carefully staged approach—often including genetic counseling and sometimes psychosocial assessment—to ensure you are fully prepared for the emotional, practical, and medical implications ^[1]. The process involves confirming the exact genetic variant in your family, discussing potential results and their uncertainties, providing informed consent, and planning for post-test support, regardless of whether you test positive, negative, or decide not to test at all ^[1][2].

The Pre-Test Phase: Counseling and Preparation

The safest framework for predictive testing usually involves a structured process led by a specialist genetic counselor, sometimes alongside a neurologist ^[1]. During this phase, you are free to pause, postpone, or decline testing at any point ^[1][3]. Testing protocols vary by clinic, so your care team will explain their specific steps.

Confirming the Familial Variant

Before you can be tested, doctors ideally need to identify the exact pathogenic PRNP gene variant in an affected family member ^[2]. FFI is classically associated with a specific mutation (D178N) occurring alongside a specific genetic feature called the 129M haplotype ^[4][2]. A predictive test in a healthy relative is only truly informative if the specific mutation causing the disease in the family is already known ^[2]. If your family’s variant has not been identified, your test results may be difficult or impossible to interpret clearly.

Understanding Uncertainty

Counseling will focus heavily on what the test can and cannot tell you. While a positive result indicates a high risk of developing a genetic prion disease, the exact age when symptoms might begin and how the disease will progress can vary widely, even among members of the same family ^[4][2]. A positive result does not mean you currently have FFI, nor can it predict your specific timeline ^[4].

Practical Consequences and Privacy

You will discuss the legal and practical implications of having a genetic test on your medical record. In the United States, the Genetic Information Nondiscrimination Act (GINA) provides protections regarding health insurance and employment. However, GINA does not protect you against discrimination for life, disability, or long-term care insurance ^[5][6]. Counselors will help you navigate privacy concerns, data ownership, and what protections apply to your situation ^[6]. While truly anonymous clinical testing is rarely possible, your team can help you plan how your records are stored and who has access to them.

Family and Reproductive Implications

FFI is an autosomal dominant condition. This means that if you carry the familial variant, there is a 50% chance of passing it to each biological child ^[2][7]. Pre-test counseling provides a safe space to discuss how results might impact your family planning and to explore available reproductive options, such as preimplantation genetic testing (PGT-M) or prenatal diagnosis ^[8][9]. You will also discuss whether and how you might share your results with other family members ^[9][10]. Note that predictive testing is generally reserved for adults; testing minors for adult-onset conditions without a childhood medical benefit is not recommended.

Informed Consent

Before any sample is collected, you will go through an informed consent process. This formalizes your understanding of the test’s purpose, its limitations, possible outcomes, and who will receive your results ^[11][5].

Receiving Results: The Post-Test Visit

If you proceed with testing, results are usually delivered during a dedicated, private visit—often in person, though telehealth is sometimes used ^[1]. You will decide beforehand who you want to bring with you for support ^[1].

Possible results include:

• Positive: You carry the familial PRNP mutation, meaning you are at a high risk of developing the disease. It does not mean you currently have symptoms. While there is no proven preventive therapy, your team will discuss ongoing symptom monitoring, advance care planning, and whether you might be eligible for observational research or future clinical trials ^[12][2].
• True Negative: You did not inherit the known familial mutation. This is highly reassuring and returns your risk of prion disease to the general population baseline. It does not literally eliminate the risk of sporadic (spontaneous) prion disease, but that risk is extraordinarily rare ^[2][13].
• Uninformative: If your family’s exact mutation was never identified, a negative test cannot completely rule out an inherited risk.
• Uncertain: Occasionally, broader testing might reveal a variant of unknown significance (VUS). This means a genetic change was found, but there is not enough evidence to know if it causes disease ^[14][15]. A VUS should not be treated as a positive result or used to make medical or reproductive decisions; it requires genetics follow-up as classifications can change over time.

Emotional Support and the Right Not to Know

Post-test follow-up is a critical part of the process, and emotional support should be available regardless of the outcome ^[1].

It is a common misconception that testing negative or deciding not to test will eliminate anxiety. Studies of people at risk for inherited prion diseases show that the psychological burden can be high across all groups: those who test positive, those who test negative, and those who remain untested ^[16]. Testing does not necessarily resolve family-related distress, and surviving family members who test negative sometimes experience “survivor’s guilt” ^[16].

Because of this, comprehensive care involves ongoing mental health support. Small studies have suggested that therapies focusing on coping with uncertainty, such as Acceptance and Commitment Therapy (ACT), may help some people at risk for inherited prion diseases manage anxiety and improve their quality of life, offering a potential tool for support ^[17].

Finally, the right not to know is a fundamental principle. You always have the option to decline testing or stop the process ^[18][3]. Many people choose not to learn their genetic status, and clinical teams are prepared to support you and accommodate this choice while still providing excellent medical care ^[18].